Success in treating juvenile diabetes

Israel’s Andromeda Biotech has reported success in the Phase III clinical trial of its Diapep277 drug for the treatment of Type 1 (juvenile) diabetes. The trial met its primary and secondary endpoints, and was found to be effective and safe.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.